August 28, 2025 · Form 4 insider transaction
Mahadevia Ankit sold 6,572 shares of Spero Therapeutics Inc. at $1.97 per share, a transaction worth $12.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 6 days after the transaction.
The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of restricted stock unit ("RSUs") that were granted to the Reporting Person on August 26, 2021.; Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.